Skip to main content
Carelabs Co.,Ltd logo

Carelabs Co.,Ltd — Investor Relations & Filings

Ticker · 263700 ISIN · KR7263700007 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 455 across all filing types
Latest filing 2020-03-17 Audit Report / Informat…
Country KR South Korea
Listing KO 263700

About Carelabs Co.,Ltd

https://www.carelabs.co.kr/

Carelabs Co., Ltd. is a platform company that provides comprehensive IT services for the healthcare and beauty care sectors. The company develops and operates solutions aimed at creating a more convenient and accessible healthcare ecosystem by resolving imbalances in medical information. Its core services include specialized customer relationship management (CRM) software for hospitals, such as 'SmartCRM' and 'UnoCRM', which support patient management and marketing activities. Additionally, Carelabs offers performance-based digital marketing services tailored to clients in the medical field. Through its technology-driven platforms, the company facilitates online-to-offline (O2O) connections within the health and beauty markets.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains the auditor's opinion, key financial data (assets, liabilities, equity, profit/loss), and details regarding the audit firm. While it provides financial data, it is a specific regulatory disclosure of the audit results rather than a full 10-K annual report or a simple announcement of report publication. Given the focus on audit opinions and financial statements, it falls under the Audit Report/Information category. FY 2019
2020-03-17 Korean
[기재정정]주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a regulatory filing from Carelabs regarding a 'Decision to enter into a trust agreement for the acquisition of treasury shares' (자기주식취득 신탁계약 체결 결정). This type of filing, which details the company's decision to buy back its own shares through a trust, falls under the category of 'Transaction in Own Shares'.
2020-03-17 Korean
투자판단관련주요경영사항(최대주주 지분매각 관련 우선협상대상자 선정의 건)
M&A Activity Classification · 95% confidence The document is a regulatory filing from Carelabs regarding the selection of a preferred bidder for the sale of the largest shareholder's stake. This type of corporate announcement regarding M&A activity, specifically the sale of a controlling interest, falls under the category of M&A Activity (TAR).
2020-03-13 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Carelabs Co., Ltd. It includes the meeting date, location, agenda items (financial statements, board changes, etc.), and detailed management information (business overview, market analysis, and board activities). This type of document is standard for providing shareholders with the necessary information to vote at an Annual General Meeting (AGM). In the context of the provided filing types, this is a Proxy Solicitation & Information Statement (PSI) as it contains the agenda and information required for shareholders to exercise their voting rights.
2020-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Solicitation' (위임권유) filed by Carelabs (주식회사 케어랩스) for their upcoming Annual General Meeting. It contains details about the solicitor, the purpose of the solicitation (securing quorum for the AGM), the meeting date and location, and detailed information regarding the agenda items (financial statements, business overview, etc.). This is a standard document provided to shareholders to request their votes, which falls under the Proxy Solicitation & Information Statement category.
2020-03-12 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Pledge of Shares' (주식 담보제공 계약) that involves a change in the largest shareholder. This type of disclosure is a standard regulatory requirement for listed companies to report changes in share collateralization and ownership structure. Since it is a specific regulatory filing regarding share collateralization and does not fit into the other categories like 10-K, ER, or DIRS (which is for individual director trades), it is classified as a Regulatory Filing (RNS).
2020-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.